Loading…

Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study

Background: Insulin resistance (IR) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-II diabetes and cardiometabolic diseases. One of the reasons leading to its increased and early incidenc...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacognosy research 2015-04, Vol.7 (2), p.166-175
Main Authors: Mathur, R, Dutta, Shagun, Velpandian, T, Mathur, S
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c608r-dffd254e670825678c6ebdc8f9a85993868f8e7b8aad351517ba07a965a2be853
cites
container_end_page 175
container_issue 2
container_start_page 166
container_title Pharmacognosy research
container_volume 7
creator Mathur, R
Dutta, Shagun
Velpandian, T
Mathur, S
description Background: Insulin resistance (IR) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-II diabetes and cardiometabolic diseases. One of the reasons leading to its increased and early incidence is understood to be a high intake of processed fructose containing foods and beverages by individuals, especially, during critical developmental years. Objective: To investigate the preventive potential of aqueous extract of Psidium guajava leaves (PG) against metabolic pathologies, vis-à-vis, IR, dyslipidemia, hyperleptinemia and hypertension, due to excess fructose intake initiated during developmental years. Materials and Methods: Post-weaning (4 weeks old) male rats were provided fructose (15%) as drinking solution, ad libitum, for 8 weeks and assessed for food and water/fructose intake, body weight, fasting blood sugar, mean arterial pressure, lipid biochemistry, endocrinal (insulin, leptin), histopathological (fatty liver) and immunohistochemical (hepatic glucose transporter [GLUT2]) parameters. Parallel treatment groups were administered PG in doses of 250 and 500 mg/kg/d, po × 8 weeks and assessed for same parameters. Using extensive liquid chromatography-mass spectrometry protocols, PG was analyzed for the presence of phytoconstituents like Myrecetin, Luteolin, Kaempferol and Guavanoic acid and validated to contain Quercetin up to 9.9%w/w. Results: High fructose intake raised circulating levels of insulin and leptin and hepatic GLUT2 expression to promote IR, dyslipidemia, and hypertension that were favorably re-set with PG. Although PG is known for its beneficial role in diabetes mellitus, for the first time we report its potential in the management of lifelong pathologies arising from high fructose intake initiated during developmental years.
doi_str_mv 10.4103/0974-8490.151459
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4357967</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A402688395</galeid><sourcerecordid>A402688395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c608r-dffd254e670825678c6ebdc8f9a85993868f8e7b8aad351517ba07a965a2be853</originalsourceid><addsrcrecordid>eNptkk2P0zAQhiMEYlfL3jkhS1y4tDjfNgekasWXVAkOcLamzrh1m9rFdrZbiT_FP8RWs6VFJIdYnvd9NTN5suxlTqdVTsu3lLfVhFWcTvM6r2r-JLs-XT09O19lt96vaXxKXvAqf55dFTUreMvpdfb7m9edHrZkOcAa7oHMtTFT0iMogg_BgQwElEIZPFnhDoKWZNkP0noksWr8zrqAblKQYAmEgGaAgATB9QdijcdArCLa-KHXhjj02gcwEolMxZ8DmpCcK71cEeUGGVKwNgE2-I7MTOxhh05vowx64sPQHV5kzxT0Hm_H70324-OH73efJ_Ovn77czeYT2VDmJp1SXVFX2LSUFXXTMtngopNMcWA15yVrmGLYLhhAV9Zxg-0CaAu8qaFYIKvLm-z9MXc3LLbYydiCg17sYjfgDsKCFpcVo1diae9FVdYtb9oY8GYMcDYO6oPYai-x78GgHbzIm4ZXNW04i9LX_0jXdnAmjifytixazvK6-ataQo9CG2XT_0mhYlbRomGs5Knv6X9U8e1wq-PWUel4f2GgR4N01nuH6jRjTkUiTSSUREJJHEmLllfnuzkZHrmKgl9Hwd72EQ-_6Yc9OhG1G2P3F8GTs-C0EzESKUYiRSJSJCDFCKQYgRQjkGIEUjwCWf4BLOr-8Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1732798156</pqid></control><display><type>article</type><title>Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Mathur, R ; Dutta, Shagun ; Velpandian, T ; Mathur, S</creator><creatorcontrib>Mathur, R ; Dutta, Shagun ; Velpandian, T ; Mathur, S</creatorcontrib><description>Background: Insulin resistance (IR) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-II diabetes and cardiometabolic diseases. One of the reasons leading to its increased and early incidence is understood to be a high intake of processed fructose containing foods and beverages by individuals, especially, during critical developmental years. Objective: To investigate the preventive potential of aqueous extract of Psidium guajava leaves (PG) against metabolic pathologies, vis-à-vis, IR, dyslipidemia, hyperleptinemia and hypertension, due to excess fructose intake initiated during developmental years. Materials and Methods: Post-weaning (4 weeks old) male rats were provided fructose (15%) as drinking solution, ad libitum, for 8 weeks and assessed for food and water/fructose intake, body weight, fasting blood sugar, mean arterial pressure, lipid biochemistry, endocrinal (insulin, leptin), histopathological (fatty liver) and immunohistochemical (hepatic glucose transporter [GLUT2]) parameters. Parallel treatment groups were administered PG in doses of 250 and 500 mg/kg/d, po × 8 weeks and assessed for same parameters. Using extensive liquid chromatography-mass spectrometry protocols, PG was analyzed for the presence of phytoconstituents like Myrecetin, Luteolin, Kaempferol and Guavanoic acid and validated to contain Quercetin up to 9.9%w/w. Results: High fructose intake raised circulating levels of insulin and leptin and hepatic GLUT2 expression to promote IR, dyslipidemia, and hypertension that were favorably re-set with PG. Although PG is known for its beneficial role in diabetes mellitus, for the first time we report its potential in the management of lifelong pathologies arising from high fructose intake initiated during developmental years.</description><identifier>ISSN: 0974-8490</identifier><identifier>ISSN: 0976-4836</identifier><identifier>EISSN: 0974-8490</identifier><identifier>DOI: 10.4103/0974-8490.151459</identifier><identifier>PMID: 25829790</identifier><language>eng</language><publisher>India: Medknow Publications Pvt Ltd</publisher><subject>Animals ; Aqueous solutions ; Chromatography ; Diabetes ; Fructose ; Glucose ; Herbal medicine ; Hypertension ; Insulin resistance ; Liver diseases ; Mass spectrometry ; Metabolism ; Original ; Rodents ; Scientific imaging ; Software</subject><ispartof>Pharmacognosy research, 2015-04, Vol.7 (2), p.166-175</ispartof><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Apr-Jun 2015</rights><rights>Copyright: © Pharmacognosy Research 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c608r-dffd254e670825678c6ebdc8f9a85993868f8e7b8aad351517ba07a965a2be853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357967/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1732798156?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25829790$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mathur, R</creatorcontrib><creatorcontrib>Dutta, Shagun</creatorcontrib><creatorcontrib>Velpandian, T</creatorcontrib><creatorcontrib>Mathur, S</creatorcontrib><title>Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study</title><title>Pharmacognosy research</title><addtitle>Pharmacognosy Res</addtitle><description>Background: Insulin resistance (IR) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-II diabetes and cardiometabolic diseases. One of the reasons leading to its increased and early incidence is understood to be a high intake of processed fructose containing foods and beverages by individuals, especially, during critical developmental years. Objective: To investigate the preventive potential of aqueous extract of Psidium guajava leaves (PG) against metabolic pathologies, vis-à-vis, IR, dyslipidemia, hyperleptinemia and hypertension, due to excess fructose intake initiated during developmental years. Materials and Methods: Post-weaning (4 weeks old) male rats were provided fructose (15%) as drinking solution, ad libitum, for 8 weeks and assessed for food and water/fructose intake, body weight, fasting blood sugar, mean arterial pressure, lipid biochemistry, endocrinal (insulin, leptin), histopathological (fatty liver) and immunohistochemical (hepatic glucose transporter [GLUT2]) parameters. Parallel treatment groups were administered PG in doses of 250 and 500 mg/kg/d, po × 8 weeks and assessed for same parameters. Using extensive liquid chromatography-mass spectrometry protocols, PG was analyzed for the presence of phytoconstituents like Myrecetin, Luteolin, Kaempferol and Guavanoic acid and validated to contain Quercetin up to 9.9%w/w. Results: High fructose intake raised circulating levels of insulin and leptin and hepatic GLUT2 expression to promote IR, dyslipidemia, and hypertension that were favorably re-set with PG. Although PG is known for its beneficial role in diabetes mellitus, for the first time we report its potential in the management of lifelong pathologies arising from high fructose intake initiated during developmental years.</description><subject>Animals</subject><subject>Aqueous solutions</subject><subject>Chromatography</subject><subject>Diabetes</subject><subject>Fructose</subject><subject>Glucose</subject><subject>Herbal medicine</subject><subject>Hypertension</subject><subject>Insulin resistance</subject><subject>Liver diseases</subject><subject>Mass spectrometry</subject><subject>Metabolism</subject><subject>Original</subject><subject>Rodents</subject><subject>Scientific imaging</subject><subject>Software</subject><issn>0974-8490</issn><issn>0976-4836</issn><issn>0974-8490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk2P0zAQhiMEYlfL3jkhS1y4tDjfNgekasWXVAkOcLamzrh1m9rFdrZbiT_FP8RWs6VFJIdYnvd9NTN5suxlTqdVTsu3lLfVhFWcTvM6r2r-JLs-XT09O19lt96vaXxKXvAqf55dFTUreMvpdfb7m9edHrZkOcAa7oHMtTFT0iMogg_BgQwElEIZPFnhDoKWZNkP0noksWr8zrqAblKQYAmEgGaAgATB9QdijcdArCLa-KHXhjj02gcwEolMxZ8DmpCcK71cEeUGGVKwNgE2-I7MTOxhh05vowx64sPQHV5kzxT0Hm_H70324-OH73efJ_Ovn77czeYT2VDmJp1SXVFX2LSUFXXTMtngopNMcWA15yVrmGLYLhhAV9Zxg-0CaAu8qaFYIKvLm-z9MXc3LLbYydiCg17sYjfgDsKCFpcVo1diae9FVdYtb9oY8GYMcDYO6oPYai-x78GgHbzIm4ZXNW04i9LX_0jXdnAmjifytixazvK6-ataQo9CG2XT_0mhYlbRomGs5Knv6X9U8e1wq-PWUel4f2GgR4N01nuH6jRjTkUiTSSUREJJHEmLllfnuzkZHrmKgl9Hwd72EQ-_6Yc9OhG1G2P3F8GTs-C0EzESKUYiRSJSJCDFCKQYgRQjkGIEUjwCWf4BLOr-8Q</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Mathur, R</creator><creator>Dutta, Shagun</creator><creator>Velpandian, T</creator><creator>Mathur, S</creator><general>Medknow Publications Pvt Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Phcog.net</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150401</creationdate><title>Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study</title><author>Mathur, R ; Dutta, Shagun ; Velpandian, T ; Mathur, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c608r-dffd254e670825678c6ebdc8f9a85993868f8e7b8aad351517ba07a965a2be853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Aqueous solutions</topic><topic>Chromatography</topic><topic>Diabetes</topic><topic>Fructose</topic><topic>Glucose</topic><topic>Herbal medicine</topic><topic>Hypertension</topic><topic>Insulin resistance</topic><topic>Liver diseases</topic><topic>Mass spectrometry</topic><topic>Metabolism</topic><topic>Original</topic><topic>Rodents</topic><topic>Scientific imaging</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mathur, R</creatorcontrib><creatorcontrib>Dutta, Shagun</creatorcontrib><creatorcontrib>Velpandian, T</creatorcontrib><creatorcontrib>Mathur, S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pharmacognosy research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mathur, R</au><au>Dutta, Shagun</au><au>Velpandian, T</au><au>Mathur, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study</atitle><jtitle>Pharmacognosy research</jtitle><addtitle>Pharmacognosy Res</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>7</volume><issue>2</issue><spage>166</spage><epage>175</epage><pages>166-175</pages><issn>0974-8490</issn><issn>0976-4836</issn><eissn>0974-8490</eissn><abstract>Background: Insulin resistance (IR) is amalgam of pathologies like altered glucos metabolism, dyslipidemia, impaired glucose tolerance, non-alcoholic fatty liver disease, and associated with type-II diabetes and cardiometabolic diseases. One of the reasons leading to its increased and early incidence is understood to be a high intake of processed fructose containing foods and beverages by individuals, especially, during critical developmental years. Objective: To investigate the preventive potential of aqueous extract of Psidium guajava leaves (PG) against metabolic pathologies, vis-à-vis, IR, dyslipidemia, hyperleptinemia and hypertension, due to excess fructose intake initiated during developmental years. Materials and Methods: Post-weaning (4 weeks old) male rats were provided fructose (15%) as drinking solution, ad libitum, for 8 weeks and assessed for food and water/fructose intake, body weight, fasting blood sugar, mean arterial pressure, lipid biochemistry, endocrinal (insulin, leptin), histopathological (fatty liver) and immunohistochemical (hepatic glucose transporter [GLUT2]) parameters. Parallel treatment groups were administered PG in doses of 250 and 500 mg/kg/d, po × 8 weeks and assessed for same parameters. Using extensive liquid chromatography-mass spectrometry protocols, PG was analyzed for the presence of phytoconstituents like Myrecetin, Luteolin, Kaempferol and Guavanoic acid and validated to contain Quercetin up to 9.9%w/w. Results: High fructose intake raised circulating levels of insulin and leptin and hepatic GLUT2 expression to promote IR, dyslipidemia, and hypertension that were favorably re-set with PG. Although PG is known for its beneficial role in diabetes mellitus, for the first time we report its potential in the management of lifelong pathologies arising from high fructose intake initiated during developmental years.</abstract><cop>India</cop><pub>Medknow Publications Pvt Ltd</pub><pmid>25829790</pmid><doi>10.4103/0974-8490.151459</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0974-8490
ispartof Pharmacognosy research, 2015-04, Vol.7 (2), p.166-175
issn 0974-8490
0976-4836
0974-8490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4357967
source PubMed (Medline); Publicly Available Content Database
subjects Animals
Aqueous solutions
Chromatography
Diabetes
Fructose
Glucose
Herbal medicine
Hypertension
Insulin resistance
Liver diseases
Mass spectrometry
Metabolism
Original
Rodents
Scientific imaging
Software
title Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: An experimental study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A32%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Psidium%20guajava%20Linn.%20leaf%20extract%20affects%20hepatic%20glucose%20transporter-2%20to%20attenuate%20early%20onset%20of%20insulin%20resistance%20consequent%20to%20high%20fructose%20intake:%20An%20experimental%20study&rft.jtitle=Pharmacognosy%20research&rft.au=Mathur,%20R&rft.date=2015-04-01&rft.volume=7&rft.issue=2&rft.spage=166&rft.epage=175&rft.pages=166-175&rft.issn=0974-8490&rft.eissn=0974-8490&rft_id=info:doi/10.4103/0974-8490.151459&rft_dat=%3Cgale_pubme%3EA402688395%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c608r-dffd254e670825678c6ebdc8f9a85993868f8e7b8aad351517ba07a965a2be853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1732798156&rft_id=info:pmid/25829790&rft_galeid=A402688395&rfr_iscdi=true